P2RX7 and melanoma: Accordingly, stable transfection of the colon carcinoma tumor model CT26 with a P2X7 expression vector accelerated tumor growth in vivo (28), and P2X7 blockade using oxidized ATP (oATP), a poorly selective but irreversible antagonist, reduced melanoma B16 tumor growth in vivo (29).